News
Brainomix’s e-Lung enters TIPAL trial
Brainomix has revealed that it will be partnering with the TIPAL trial group to deliver a sub-study that analyses the efficacy of its e-Lung platform.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Brainomix has revealed that it will be partnering with the TIPAL trial group to deliver a sub-study that analyses the efficacy of its e-Lung platform.